Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
In a recent study, administration of granulocyte colony stimulating factor (G-CSF) increased neuromyelitis optica (NMO) lesions in mice. Here we report a patient whose first episode of NMO may have been exacerbated by inadvertent administration of G-CSF. Histological examination of brain and spinal...
Main Authors: | Jacob, A, Saadoun, S, Kitley, J, Leite, M, Palace, J, Schon, F, Papadopoulos, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2012
|
Registos relacionados
-
Use of mitoxantrone in neuromyelitis optica.
Por: Kitley, J, et al.
Publicado em: (2011) -
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
Por: Kitley, J, et al.
Publicado em: (2014) -
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
Por: Kitley, J, et al.
Publicado em: (2014) -
METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
Por: Kitley, J, et al.
Publicado em: (2012) -
NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
Por: Luppe, S, et al.
Publicado em: (2012)